Showing results (2371-2380 of 3,512) with videos related to

Sort By:
Pageof 352
Eclinicalmedicine|January 13, 2025
Global assessment of leukemia care quality: insights from the quality of care index (QCI) from 1990 to 2021Yuzhe Pan, Qian Liu, Nan Zhang, et al.
Eclinicalmedicine|January 10, 2025
Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trialKatrine Lundby Høyer, Simon Mark Dahl Baunwall, Ditte Smed Kornum, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
Eclinicalmedicine|February 3, 2025
Post infectious fatigue and circadian rhythm disruption in long-COVID and other infections: a need for further researchAchilleas Livieratos, Steven W Lockley, Sotirios Tsiodras
Eclinicalmedicine|February 3, 2025
Prediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation studyHayeon Lee, Seung Ha Hwang, Seoyoung Park, et al.
Eclinicalmedicine|February 6, 2025
Serum NFL and neuropsychological performance over ∼8 years in women with and without HIV: a longitudinal repeated measures studyDeborah R Gustafson, Xuantao Li, Alison E Baird, et al.
Eclinicalmedicine|January 7, 2025
The literacy barrier in clinical trial consents: a retrospective analysisFatima N Mirza, Eric Wu, Hael F Abdulrazeq, et al.
Eclinicalmedicine|January 7, 2025
L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialTomohiko Ishihara, Masayoshi Tada, Yoshitomi Kanemitsu, et al.
Eclinicalmedicine|January 7, 2025
Syphilis infection prevalence in the Middle East and North Africa: a systematic review and meta-analysisMariam El-Jamal, Beyhan Annan, Alaa Al Tawil, et al.
Eclinicalmedicine|December 31, 2024
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trialAbha A Gupta, Anna Tinker, Derek Jonker, et al.
Pageof 352